Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-063324
Filing Date
2023-05-22
Accepted
2023-05-22 21:21:22
Documents
1
Period of Report
2023-05-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2316485-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2316485-2_4seq1.xml 4 3126
  Complete submission text file 0001104659-23-063324.txt   4678
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
RVL Pharmaceuticals plc (Issuer) CIK: 0001739426 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 CROSSING BOULEVARD C/O OSMOTICA PHARMACEUTICALS PLC BRIDGEWATER NJ 08807
Business Address
Schaub James (Reporting) CIK: 0001752153 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38709 | Film No.: 23946355